๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Budesonide - Medicines in Ireland

35 authorised products containing Budesonide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 35 authorised medicines
MedicineActive substanceLicence holderStatus
AirBuFo Forspiro 160 microgram/4.5 microgram/dose inhalation powder, pre-dispensed
PA0711/284/001
Budesonide, Formoterol fumarate dihydrate Rowex Limited, Marketed
AirBuFo Forspiro 320 microgram/9 microgram/dose inhalation powder, pre-dispensed
PA0711/284/002
Budesonide, Formoterol fumarate dihydrate Rowex Limited, Marketed
BiResp Spiromax 160 micrograms/4.5 micrograms inhalation powder
EU/1/14/921/001-003
Budesonide, Formoterol fumarate dihydrate Teva Pharma B.V. โ€”
BiResp Spiromax 320 micrograms/9 micrograms inhalation powder
EU/1/14/921/004-006
Budesonide, Formoterol fumarate dihydrate Teva Pharma B.V. โ€”
Budenofalk 2mg/dose rectal foam
PA0573/002/002
Budesonide Dr. Falk Pharma GmbH Marketed
Budenofalk 3 mg gastro-resistant capsules
PA0573/002/001
Budesonide Dr. Falk Pharma GmbH Marketed
Budenofalk 4 mg suppositories
PA0573/008/001
Budesonide Dr. Falk Pharma GmbH Not marketed
Budenofalkยฎ 9mg gastro-resistant granules
PA0573/002/003
Budesonide Dr. Falk Pharma GmbH Marketed
Budesonide Azure 0.5 mg/2 ml Nebuliser Suspension
PA22871/035/001
Budesonide Azure Pharmaceuticals Ltd. Not marketed
Budesonide Azure 1 mg/2 ml Nebuliser Suspension
PA22871/035/002
Budesonide Azure Pharmaceuticals Ltd. Not marketed
Budesonide Teva Pharma 0.5 mg/2 ml Nebuliser Suspension
PA0749/207/002
Budesonide Teva Pharma B.V. Marketed
Budesonide Teva Pharma 1 mg/2 ml Nebuliser Suspension
PA0749/207/003
Budesonide Teva Pharma B.V. Marketed
Bufomix Easyhaler 160 micrograms/4.5 micrograms/inhalation, inhalation powder
PA1327/015/002
Budesonide, Formoterol fumarate dihydrate Orion Corporation Marketed
Bufomix Easyhaler 320 micrograms/9 micrograms/inhalation, inhalation powder
PA1327/015/003
Budesonide, Formoterol fumarate dihydrate Orion Corporation Marketed
Bufomix Easyhaler 80 micrograms/4.5 micrograms/inhalation, inhalation powder
PA1327/015/004
Budesonide, Formoterol fumarate dihydrate Orion Corporation Marketed
Cortiment 9 mg prolonged release tablets
PA1009/026/001
Budesonide Ferring Ireland Ltd Marketed
DuoResp Spiromax 160 micrograms/4.5 micrograms inhalation powder
EU/1/14/920 /001-003
Budesonide, Formoterol fumatrate dihydrate Teva Pharma B.V. โ€”
DuoResp Spiromax 320 micrograms/9 micrograms inhalation powder
EU/1/14/920 /004-006
Budesonide, Formoterol fumatrate dihydrate Teva Pharma B.V. โ€”
Entocort CR 3 mg Gastro-resistant Capsule, Hard
PA2018/003/001
Budesonide Tillotts Pharma GmbH Marketed
GoResp Digihaler 160 microgram/4.5 microgram inhalation powder
EU/1/19/1403/001-003
Budesonide, Formoterol fumarate dihydrate Teva Pharma B.V. โ€”
GoResp Digihaler 320 microgram/9 microgram inhalation powder
EU/1/19/1403/004-005
Budesonide, Formoterol fumarate dihydrate Teva Pharma B.V. โ€”
Jorveza 0.5 mg orodispersible tablets
EU/1/17/1254/007-011
Budesonide Dr. Falk Pharma GmbH โ€”
Jorveza 1 mg orodispersible tablets
EU/1/17/1254/001-005
Budesonide Dr. Falk Pharma GmbH โ€”
Pinacort 3 mg modified release hard capsules
PA0281/251/001
Budesonide Pinewood Laboratories Ltd Marketed
Pulmicort Respules 0.5 mg/2 ml Nebuliser Suspension
PA1019/017/001
Budesonide AstraZeneca AB Marketed
Pulmicort Respules 1 mg /2 ml Nebuliser Suspension
PA1019/017/002
Budesonide AstraZeneca AB Marketed
Pulmicort Turbohaler 100 micrograms Inhalation Powder
PA1019/017/003
Budesonide AstraZeneca AB Not marketed
Pulmicort Turbohaler 200 micrograms Inhalation Powder
PA1019/017/004
Budesonide AstraZeneca AB Marketed
Pulmicort Turbohaler 400 micrograms Inhalation Powder
PA1019/017/005
Budesonide AstraZeneca AB Not marketed
Riltrava Aerosphere 5/7.2/160 micrograms pressurised inhalation, suspension
EU/1/21/1604/001-002
Formoterol fumarate dihydrate, Glycopyrronium bromide, Budesonide AstraZeneca AB โ€”
Symbicort Turbohaler 200 micrograms/6 micrograms/inhalation, inhalation powder
PPA23080/021/001
Budesonide, Formoterol fumarate dihydrate Merit Pharmaceuticals Limited โ€”
Symbicort Turbohaler, 100 micrograms /6 micrograms/inhalation, inhalation powder
PA1019/020/001
Budesonide, Formoterol fumarate dihydrate AstraZeneca AB Marketed
Symbicort Turbohaler, 400 micrograms/12 micrograms/inhalation, inhalation powder
PA1019/020/003
Budesonide, Formoterol fumatrate dihydrate AstraZeneca AB Marketed
Symbicort, 200 micrograms/6 micrograms per inhalation, pressurised inhalation, suspension
PA1019/020/004
Formoterol fumarate dihydrate (micronised), Budesonide AstraZeneca AB Not marketed
Symbicortยฎ Turbohaler; 200 micrograms/6 micrograms/inhalation, inhalation powder
PA1019/020/002
Budesonide, Formoterol fumatrate dihydrate AstraZeneca AB Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.